Evidence map›Paper›PMID 27689008›Full record

ArticleMolecular metabolism2016

Adipose tissue (P)RR regulates insulin sensitivity, fat mass and body weight.

Zulaykho Shamansurova, Paul Tan, Basma Ahmed, Emilie Pepin, Ondrej Seda, Julie L Lavoie

Abstract read
In one paragraph

Article in Molecular metabolism, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. The (pro)renin receptor as a pharmacological target in cardiorenal diseaes.Hypertension research : official journal of the Japanese Society of Hypertension · 2023
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Association of Ang-(1-7) and des-ArgHypertension research : official journal of the Japanese Society of Hypertension · 2021
    Article
  11. The (pro)renin receptor in health and disease.Nature reviews. Nephrology · 2019
    Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. The prorenin receptor in the cardiovascular system and beyond.American journal of physiology. Heart and circulatory physiology · 2018
    Review
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zulaykho ShamansurovaCentre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Université de Montréal, Quebec, Canada; Department of Physiology, Université de Montréal, Quebec, Canada; Montreal Diabetes Research Center, Quebec, Canada.
Paul TanCentre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Université de Montréal, Quebec, Canada; Department of Biochemistry and Molecular Medicine, Université de Montréal, Quebec, Canada; Montreal Diabetes Research Center, Quebec, Canada.
Basma AhmedCentre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Université de Montréal, Quebec, Canada; Department of Physiology, Université de Montréal, Quebec, Canada.
Emilie PepinCentre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Université de Montréal, Quebec, Canada; Montreal Diabetes Research Center, Quebec, Canada.
Ondrej SedaCentre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Université de Montréal, Quebec, Canada; First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
Julie L LavoieCentre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Université de Montréal, Quebec, Canada; Department of Kinesiology, Université de Montréal, Quebec, Canada; Montreal Diabetes Research Center, Quebec, Canada. Electronic address: julie.lavoie.3@umontreal.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWe previously demonstrated that the handle-region peptide, a prorenin/renin receptor [(P)RR] blocker, reduces body weight and fat mass and may improve insulin sensitivity in high-fat fed mice. We hypothesized that knocking out the adipose tissue (P)RR gene would prevent weight gain and insulin resistance.

methodsAn adipose tissue-specific (P)RR knockout (KO) mouse was created by Cre-loxP technology using AP2-Cre recombinase mice. Because the (P)RR gene is located on the X chromosome, hemizygous males were complete KO and had a more pronounced phenotype on a normal diet (ND) diet compared to heterozygous KO females. Therefore, we challenged the female mice with a high-fat diet (HFD) to uncover certain phenotypes. Mice were maintained on either diet for 9 weeks.

resultsKO mice had lower body weights compared to wild-types (WT). Only hemizygous male KO mice presented with lower total fat mass, higher total lean mass as well as smaller adipocytes compared to WT mice. Although food intake was similar between genotypes, locomotor activity during the active period was increased in both male and female KO mice. Interestingly, only male KO mice had increased O2 consumption and CO2 production during the entire 24-hour period, suggesting an increased basal metabolic rate. Although glycemia during a glucose tolerance test was similar, KO males as well as HFD-fed females had lower plasma insulin and C-peptide levels compared to WT mice, suggesting improved insulin sensitivity. Remarkably, all KO animals exhibited higher circulating adiponectin levels, suggesting that this phenotype can occur even in the absence of a significant reduction in adipose tissue weight, as observed in females and, thus, may be a specific effect related to the (P)RR.

conclusions(P)RR may be an important therapeutic target for the treatment of obesity and its associated complications such as type 2 diabetes.

Indexed as

Adipose tissueAdipose tissue knock-out miceANG, AngiotensinBAT, brown adipose tissueBB, beam breakHACT, horizontal activityHFD, high-fat dietHRP, handle-region peptideInsulin resistanceKO, knock-outND, normal dietObesityOGTT, oral glucose tolerance testPGF, perigonadal fatPPAR-γ, peroxisome proliferator-activated receptor-γPRA, plasma renin activityPRF, perirenal fat(Pro)renin receptor(P)RR, prorenin/renin receptorRAS, renin-angiotensin systemRenin-angiotensin systemSE, standard errorSFC, abdominal subcutaneous fatSMG, submandibular glandSM, skeletal muscleTG, triglyceridesV-ATPase, vacuolar proton pump H+-ATPaseVCO2, carbon dioxide productionVO2, oxygen consumptionWT, wild-type

Identifiers

PMID27689008
PMCPMC5034688

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.